Cholera Classification and external resources
Scanning electron microscope image of Vibrio cholerae
ICD-10 A00 ICD-9 001 DiseasesDB 29089 MedlinePlus 000303 eMedicine med/351 MeSH D002771
Cholera is an infection of the small intestine that is caused by the bacterium Vibrio cholerae. The main symptoms are profuse watery diarrhoea and vomiting. Transmission occurs primarily by drinking or eating water or food that has been contaminated by the diarrhea of an infected person or the feces of an infected but asymptomatic person. The severity of the diarrhea and vomiting can lead to rapid dehydration and electrolyte imbalance and death in some cases. The primary treatment is with oral rehydration solution (ORS) to replace water and electrolytes, and if this is not tolerated or doesn't provides quick enough treatment, intravenous fluids can also be used. Antibiotics are beneficial in those with severe disease to shorten the duration and severity. Worldwide it affects 3–5 million people and causes 100,000–130,000 deaths a year as of 2010[update]. Cholera was one of the earliest infections to be studied by epidemiological methods.
- 1 Signs and symptoms
- 2 Cause
- 3 Mechanism
- 4 Diagnosis
- 5 Prevention
- 6 Treatment
- 7 Prognosis
- 8 Epidemiology
- 9 History
- 10 Notable cases
- 11 References
- 12 Further reading
- 13 External links
Signs and symptoms
The primary symptoms of cholera are profuse painless diarrhea and vomiting of clear fluid. These symptoms usually start suddenly, one to five days after ingestion of the bacteria. The diarrhea is frequently described as "rice water" in nature and may have a fishy odor. An untreated person with cholera may produce 10–20 litres of diarrhea a day with fatal results. For every symptomatic person there are 3 to 100 people who get the infection but remain asymptomatic.
If the severe diarrhea and vomiting are not aggressively treated it can, within hours, result in life-threatening dehydration and electrolyte imbalances. The typical symptoms of dehydration include low blood pressure, poor skin turgor (wrinkled hands), sunken eyes, and a rapid pulse.
About one hundred million bacteria must typically be ingested to cause cholera in a normal healthy adult. This dose, however, is less in those with lower gastric acidity (for instance those using proton pump inhibitors). Children are also more susceptible with two to four year olds having the highest rates of infection. Individuals' susceptibility to cholera is also affected by their blood type, with those with type O blood being the most susceptible. Persons with lower immunity such as persons with AIDS or children who are malnourished are more likely to experience a severe case if they become infected. However, it should be noted that any particular person, even a healthy adult in middle age, can experience a severe case, and each particular person's case should be measured by their particular loss of fluids, preferably in consultation with a doctor or other health worker.
It has been said that cystic fibrosis genetic mutation in humans has maintained a selective advantage: heterozygous carriers of the mutation (who are thus not affected by cystic fibrosis) are more resistant to V. cholerae infections. In this model, the genetic deficiency in the cystic fibrosis transmembrane conductance regulator channel proteins interferes with bacteria binding to the gastrointestinal epithelium, thus reducing the effects of an infection.
Cholera is typically transmitted by either contaminated food or water. In the developed world, seafood is the usual cause, while in the developing world it is more often water. Cholera has been found in only two other animal populations: shellfish and plankton.
People infected with cholera often have diarrhea, and if this highly liquid stool, colloquially referred to as "rice-water," or "faucet butt," contaminates water used by others, disease transmission may occur. The source of the contamination is typically other cholera sufferers when their untreated diarrheal discharge is allowed to get into waterways or into groundwater or drinking water supplies. Drinking any infected water and eating any foods washed in the water, as well as shellfish living in the affected waterway, can cause a person to contract an infection. Cholera is rarely spread directly from person to person. Both toxic and nontoxic strains exist. Nontoxic strains can acquire toxicity through a temperate bacteriophage. Coastal cholera outbreaks typically follow zooplankton blooms, thus making cholera a zoonotic disease.
Most bacteria, when consumed, do not survive the acidic conditions of the human stomach. The few bacteria that do survive conserve their energy and stored nutrients during the passage through the stomach by shutting down much protein production. When the surviving bacteria exit the stomach and reach the small intestine, they need to propel themselves through the thick mucus that lines the small intestine to get to the intestinal walls, where they can thrive. V. cholerae bacteria start up production of the hollow cylindrical protein flagellin to make flagella, the cork-screw helical fibers they rotate to propel themselves through the mucus of the small intestine.
Once the cholera bacteria reach the intestinal wall, they no longer need the flagella propellers to move. The bacteria stop producing the protein flagellin, thus again conserving energy and nutrients by changing the mix of proteins which they manufacture in response to the changed chemical surroundings. On reaching the intestinal wall, V. cholerae start producing the toxic proteins that give the infected person a watery diarrhea. This carries the multiplying new generations of V. cholerae bacteria out into the drinking water of the next host if proper sanitation measures are not in place.
The cholera toxin (CTX or CT) is an oligomeric complex made up of six protein subunits: a single copy of the A subunit (part A), and five copies of the B subunit (part B), connected by a disulfide bond. The five B subunits form a five-membered ring that binds to GM1 gangliosides on the surface of the intestinal epithelium cells. The A1 portion of the A subunit is an enzyme that ADP-ribosylates G proteins, while the A2 chain fits into the central pore of the B subunit ring. Upon binding, the complex is taken into the cell via receptor-mediated endocytosis. Once inside the cell, the disulfide bond is reduced, and the A1 subunit is freed to bind with a human partner protein called ADP-ribosylation factor 6 (Arf6). Binding exposes its active site, allowing it to permanently ribosylate the Gs alpha subunit of the heterotrimeric G protein. This results in constitutive cAMP production, which in turn leads to secretion of H2O, Na+, K+, Cl−, and HCO3− into the lumen of the small intestine and rapid dehydration. The gene encoding the cholera toxin is introduced into V. cholerae by horizontal gene transfer. Virulent strains of V. cholerae carry a variant of temperate bacteriophage called CTXf or CTXφ.
Microbiologists have studied the genetic mechanisms by which the V. cholerae bacteria turn off the production of some proteins and turn on the production of other proteins as they respond to the series of chemical environments they encounter, passing through the stomach, through the mucous layer of the small intestine, and on to the intestinal wall. Of particular interest have been the genetic mechanisms by which cholera bacteria turn on the protein production of the toxins that interact with host cell mechanisms to pump chloride ions into the small intestine, creating an ionic pressure which prevents sodium ions from entering the cell. The chloride and sodium ions create a salt-water environment in the small intestines, which through osmosis can pull up to six litres of water per day through the intestinal cells, creating the massive amounts of diarrhea. The host can become rapidly dehydrated if an appropriate mixture of dilute salt water and sugar is not taken to replace the blood's water and salts lost in the diarrhea.
By inserting separate, successive sections of V. cholerae DNA into the DNA of other bacteria, such as E. coli that would not naturally produce the protein toxins, researchers have investigated the mechanisms by which V. cholerae responds to the changing chemical environments of the stomach, mucous layers, and intestinal wall. Researchers have discovered there is a complex cascade of regulatory proteins that control expression of V. cholerae virulence determinants. In responding to the chemical environment at the intestinal wall, the V. cholerae bacteria produce the TcpP/TcpH proteins, which, together with the ToxR/ToxS proteins, activate the expression of the ToxT regulatory protein. ToxT then directly activates expression of virulence genes that produce the toxins, causing diarrhea in the infected person and allowing the bacteria to colonize the intestine. Current research aims at discovering "the signal that makes the cholera bacteria stop swimming and start to colonize (that is, adhere to the cells of) the small intestine."
Amplified fragment length polymorphism fingerprinting of the pandemic isolates of Vibrio cholerae has revealed variation in the genetic structure. Two clusters have been identified: Cluster I and Cluster II. For the most part, Cluster I consists of strains from the 1960s and 1970s, while Cluster II largely contains strains from the 1980s and 1990s, based on the change in the clone structure. This grouping of strains is best seen in the strains from the African continent.
A rapid dip-stick test is available to determine the presence of V. cholerae. In those that test positive, further testing should be done to determine antibiotic resistance. In epidemic situations, a clinical diagnosis may be made by taking a history and doing a brief examination. Treatment is usually started without or before confirmation by laboratory analysis.
Stool and swab samples collected in the acute stage of the disease, before antibiotics have been administered, are the most useful specimens for laboratory diagnosis. If an epidemic of cholera is suspected, the most common causative agent is Vibrio cholerae O1. If V. cholerae serogroup O1 is not isolated, the laboratory should test for V. cholerae O139. However, if neither of these organisms is isolated, it is necessary to send stool specimens to a reference laboratory. Infection with V. cholerae O139 should be reported and handled in the same manner as that caused by V. cholerae O1. The associated diarrheal illness should be referred to as cholera and must be reported in the United States.
A number of special media have been employed for the cultivation for cholera vibrios. They are classified as follows:
- Alkaline peptone water at pH 8.6
- Monsur's taurocholate tellurite peptone water at pH 9.2
- Alkaline bile salt agar (BSA): The colonies are very similar to those on nutrient agar.
- Monsur's gelatin Tauro cholate trypticase tellurite agar (GTTA) medium: Cholera vibrios produce small translucent colonies with a greyish black center.
- TCBS medium: This the mostly widely used medium; it contains thiosulphate, citrate, bile salts and sucrose. Cholera vibrios produce flat 2–3 mm in diameter, yellow nucleated colonies.
Direct microscopy of stool is not recommended, as it is unreliable. Microscopy is preferred only after enrichment, as this process reveals the characteristic motility of Vibrio and its inhibition by appropriate antisera. Diagnosis can be confirmed, as well, as serotyping done by agglutination with specific sera.
Although cholera may be life-threatening, prevention of the disease is normally straightforward if proper sanitation practices are followed. In developed countries, due to nearly universal advanced water treatment and sanitation practices, cholera is no longer a major health threat. The last major outbreak of cholera in the United States occurred in 1910–1911. Effective sanitation practices, if instituted and adhered to in time, are usually sufficient to stop an epidemic. There are several points along the cholera transmission path at which its spread may be halted:
- Sterilization: Proper disposal and treatment of infected fecal waste water produced by cholera victims and all contaminated materials (e.g. clothing, bedding, etc.) is essential. All materials that come in contact with cholera patients should be sterilized by washing in hot water, using chlorine bleach if possible. Hands that touch cholera patients or their clothing, bedding, etc., should be thoroughly cleaned and disinfected with chlorinated water or other effective antimicrobial agents.
- Sewage: antibacterial treatment of general sewage by chlorine, ozone, ultraviolet light or other effective treatment before it enters the waterways or underground water supplies helps prevent undiagnosed patients from inadvertently spreading the disease.
- Sources: Warnings about possible cholera contamination should be posted around contaminated water sources with directions on how to decontaminate the water (boiling, chlorination etc.) for possible use.
- Water purification: All water used for drinking, washing, or cooking should be sterilized by either boiling, chlorination, ozone water treatment, ultraviolet light sterilization (e.g. by solar water disinfection), or antimicrobial filtration in any area where cholera may be present. Chlorination and boiling are often the least expensive and most effective means of halting transmission. Cloth filters, though very basic, have significantly reduced the occurrence of cholera when used in poor villages in Bangladesh that rely on untreated surface water. Better antimicrobial filters, like those present in advanced individual water treatment hiking kits, are most effective. Public health education and adherence to appropriate sanitation practices are of primary importance to help prevent and control transmission of cholera and other diseases.
Surveillance and prompt reporting allow for containing cholera epidemics rapidly. Cholera exists as a seasonal disease in many endemic countries, occurring annually mostly during rainy seasons. Surveillance systems can provide early alerts to outbreaks, therefore leading to coordinated response and assist in preparation of preparedness plans. Efficient surveillance systems can also improve the risk assessment for potential cholera outbreaks. Understanding the seasonality and location of outbreaks provide guidance for improving cholera control activities for the most vulnerable. For prevention to be effective it is important that cases are reported to national health authorities.
A number of safe and effective oral vaccines for cholera are available. Dukoral, an orally administered, inactivated whole cell vaccine, has an overall efficacy of about 52% during the first year after being given and 62% in the second year, with minimal side effects. It is available in over 60 countries. However, it is not currently recommended by the Centers for Disease Control and Prevention (CDC) for most people traveling from the United States to endemic countries. One injectable vaccine was found to be effective for two to three years. The protective efficacy was 28% lower in children less than 5 years old. However, as of 2010, it has limited availability. Work is under way to investigate the role of mass vaccination. The World Health Organization (WHO) recommends immunization of high risk groups, such as children and people with HIV, in countries where this disease is endemic. If people are immunized broadly, herd immunity results, with a decrease in the amount of contamination in the environment.
Continued eating speeds the recovery of normal intestinal function. The World Health Organization recommends this generally for cases of diarrhea from whatever cause. A CDC training manual specifically for cholera states: “Continue to breastfeed your baby if the baby has watery diarrhea, even when traveling to get treatment. Adults and older children should continue to eat frequently.”
In most cases, cholera can be successfully treated with oral rehydration therapy (ORT),which is highly effective, safe, and simple to administer. Rice-based solutions are preferred to glucose-based ones due to greater efficiency. In severe cases with significant dehydration, intravenous rehydration may be necessary. Ringer's lactate is the preferred solution, often with added potassium. Large volumes and continued replacement until diarrhea has subsided may be needed. Ten percent of a person's body weight in fluid may need to be given in the first two to four hours. This method was first tried on a mass scale during the Bangladesh Liberation War, and was found to have much success.
If commercially produced oral rehydration solutions are too expensive or difficult to obtain, solutions can be made. One such recipe calls for 1 litre of boiled water, 1/2 teaspoon of salt, 6 teaspoons of sugar, and added mashed banana for potassium and to improve taste.
As there frequently is initially acidosis, the potassium level may be normal, even though large losses have occurred. As the dehydration is corrected, potassium levels may decrease rapidly, and thus need to be replaced.
Antibiotic treatments for one to three days shorten the course of the disease and reduce the severity of the symptoms. People will recover without them, however, if sufficient hydration is maintained. Doxycycline is typically used first line, although some strains of V. cholerae have shown resistance. Testing for resistance during an outbreak can help determine appropriate future choices. Other antibiotics that have been proven effective include cotrimoxazole, erythromycin, tetracycline, chloramphenicol, and furazolidone. Fluoroquinolones, such as norfloxacin, also may be used, but resistance has been reported.
In many areas of the world, antibiotic resistance is increasing. In Bangladesh, for example, most cases are resistant to tetracycline, trimethoprim-sulfamethoxazole, and erythromycin. Rapid diagnostic assay methods are available for the identification of multiple drug-resistant cases. New generation antimicrobials have been discovered which are effective against in in vitro studies.
An effective and relatively cheap method to prevent transmission of V. cholera is the use of folding Saris multiple times to create a simple filter. Folding Saris four to eight times may create a simple filter to reduce the amount of active V. cholera in the filtered water.. The education of proper sari filter use is imperative as there is a positive correlation and soiled saris worn by women are vectors of transmission of enteric pathogens to young children. Educating at risk populations about the proper use of the Sari filter may decrease V. cholera associated disease.
If people with cholera are treated quickly and properly, the mortality rate is less than 1%; however, with untreated cholera, the mortality rate rises to 50–60%. For certain genetic strains of cholera, such as the one present during the 2010 epidemic in Haiti and the 2004 outbreak in India, death can occur within two hours of the first sign of symptoms.
It is estimated that cholera affects 3-5 million people worldwide, and causes 100,000-130,000 deaths a year as of 2010. This occurs mainly in the developing world. In the early 1980s, death rates are believed to have been greater than 3 million a year. It is difficult to calculate exact numbers of cases, as many go unreported due to concerns that an outbreak may have a negative impact on the tourism of a country. Cholera remains both epidemic and endemic in many areas of the world.
Although much is known about the mechanisms behind the spread of cholera, this has not led to a full understanding of what makes cholera outbreaks happen some places and not others. Lack of treatment of human feces and lack of treatment of drinking water greatly facilitate its spread, but bodies of water can serve as a reservoir, and seafood shipped long distances can spread the disease. Cholera was not known in the Americas for most of the 20th century, but it reappeared towards the end of that century and seems likely to persist.
The word cholera is from Greek: χολέρα kholera from χολή kholē "bile". Cholera likely has its origins in the Indian subcontinent; it has been prevalent in the Ganges delta since ancient times. The disease first spread by trade routes (land and sea) to Russia in 1817, then to Western Europe, and from Europe to North America. There have been seven cholera pandemics in the past 200 years, with the seventh originating in Indonesia in 1961.
From a local disease, cholera became one of the most widespread and deadly diseases of the 19th century, killing an estimated tens of millions of people. In Russia alone, between 1847 and 1851, more than one million people perished of the disease. It killed 150,000 Americans during the second pandemic. Between 1900 and 1920, perhaps eight million people died of cholera in India.
Cholera became the first reportable disease in the United States due to the significant effects it had on health. John Snow, in 1854, was the first to identify the importance of contaminated water in its cause. Cholera is now no longer considered a pressing health threat in Europe and North America due to filtering and chlorination of water supplies, but still heavily affects populations in developing countries.
In the past, people traveling in ships would hang a yellow quarantine flag if one or more of the crew members suffered from cholera. Passengers from boats with a yellow flag hung would not be allowed to disembark at any harbor for an extended period, typically 30 to 40 days. In modern international maritime signal flags, the quarantine flag is yellow and black.
The term cholera morbus was used in the 19th and early 20th centuries to describe both nonepidemic cholera and other gastrointestinal diseases (sometimes epidemic) that resembled cholera. The term is not in current use, but is found in many older references. The other diseases are now known collectively as gastroenteritis.
The Russian-born bacteriologist Waldemar Haffkine developed the first cholera vaccine around 1900. The bacterium had been originally isolated forty five years earlier (1855) by Italian anatomist Filippo Pacini, but its exact nature and his results were not widely known.
One of the major contributions to fighting cholera was made by the physician and pioneer medical scientist John Snow (1813–1858), who in 1854 found a link between cholera and contaminated drinking water. Dr. Snow proposed a microbial origin for epidemic cholera in 1849. In his major "state of the art" review of 1855, he proposed a substantially complete and correct model for the etiology of the disease. In two pioneering epidemiological field studies, he was able to demonstrate human sewage contamination was the most probable disease vector in two major epidemics in London in 1854. His model was not immediately accepted, but it was seen to be the more plausible, as medical microbiology developed over the next thirty years or so.
Cities in developed nations made massive investment in clean water supply and well-separated sewage treatment infrastructures between the mid-1850s and the 1900s. This eliminated the threat of cholera epidemics from the major developed cities in the world. In 1885, Robert Koch identified V. cholerae with a microscope as the bacillus causing the disease..
Cholera has been a laboratory for the study of evolution of virulence. The province of Bengal in British India was partitioned into West Bengal and East Pakistan in 1947. Prior to partition, both regions had cholera pathogens with similar characteristics. After 1947, India made more progress on public health than East Pakistan (now Bangladesh). As a consequence,[clarification needed] the strains of the pathogen that succeeded in India had a greater incentive in the longevity of the host. They have become less virulent than the strains prevailing in Bangladesh. These draw upon the resources of the host population and rapidly kill many victims.
More recently, in 2002, Alam, et al., studied stool samples from patients at the International Centre for Diarrhoeal Disease (ICDDR) in Dhaka, Bangladesh. From the various experiments they conducted, the researchers found a correlation between the passage of V. cholerae through the human digestive system and an increased infectivity state. Furthermore, the researchers found the bacterium creates a hyperinfected state where genes that control biosynthesis of amino acids, iron uptake systems, and formation of periplasmic nitrate reductase complexes were induced just before defecation. These induced characteristics allow the cholera vibrios to survive in the "rice water" stools, an environment of limited oxygen and iron, of patients with a cholera infection.
- Tchaikovsky's death has traditionally been attributed to cholera, most probably contracted through drinking contaminated water several days earlier. Since the water was not boiled and cholera was affecting St. Petersburg, such a connection is quite plausible ...." Tchaikovsky's mother died of cholera, and his father became sick with cholera at this time but made a full recovery. Some scholars, however, including English musicologist and Tchaikovsky authority David Brown and biographer Anthony Holden, have theorized that his death was a suicide.
Other famous people believed to have died of cholera include:
- Charles X, King of France (d. 1836)
- James K. Polk, eleventh president of the United States (d. 1849) 
- Carl von Clausewitz, Prussian soldier and German military theorist (d. 1831)
- Elliott Frost, son of American poet Robert Frost (d. 1900) 
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab Sack DA, Sack RB, Nair GB, Siddique AK (January 2004). "Cholera". Lancet 363 (9404): 223–33. doi:10.1016/S0140-6736(03)15328-7. PMID 14738797.
- ^ King AA, Ionides EL, J.Luckhurst, Bouma MJ (August 2008). "Inapparent infections and cholera dynamics". Nature 454 (7206): 877–80. doi:10.1038/nature07084. PMID 18704085.
- ^ a b c d "Cholera vaccines. A brief summary of the March 2010 position paper" (PDF). World Health Organization. http://www.who.int/immunization/Cholera_PP_Accomp_letter__Mar_10_2010.pdf.
- ^ a b c d e f g h i Sack DA, Sack RB, Chaignat CL (August 2006). "Getting serious about cholera". N. Engl. J. Med. 355 (7): 649–51. doi:10.1056/NEJMp068144. PMID 16914700.
- ^ Harris JB, Khan AI, LaRocque RC, et al. (November 2005). "Blood Group, Immunity, and Risk of Infection with Vibrio cholerae in an Area of Endemicity". Infect. Immun. 73 (11): 7422–7. doi:10.1128/IAI.73.11.7422-7427.2005. PMC 1273892. PMID 16239542. http://iai.asm.org/cgi/pmidlookup?view=long&pmid=16239542.
- ^ Prevention and control of cholera outbreaks: WHO policy and recommendations, World Health Organization, Regional Office for the Eastern Mediterranean, undated but citing sources from ’07, ’04, ’03, ’04, and ’05.
- ^ Bertranpetit J, Calafell F (1996). "Genetic and geographical variability in cystic fibrosis: evolutionary considerations". Ciba Found. Symp. 197: 97–114; discussion 114–8. PMID 8827370.
- ^ Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 376–7. ISBN 0838585299.
- ^ Archivist (1997). "Cholera phage discovery". Arch Dis Child 76 (3): 274. doi:10.1136/adc.76.3.274. http://adc.bmj.com/cgi/content/extract/76/3/274.
- ^ Hartwell LH, Hood L, Goldberg ML, Reynolds AE, Silver LM, and Veres RC (2004). Genetics: From genes to genomes. Boston: Mc-Graw Hill. pp. 551–552, 572–574. (using the turning off and turning on of gene expression to make toxin proteins in cholera bacteria as a "comprehensive example" of what is known about the mechanisms by which bacteria change the mix of proteins they manufacture to respond to the changing opportunities for surviving and thriving in different chemical environments).
- ^ O'Neal C, Jobling M, Holmes R, Hol W (2005). "Structural basis for the activation of cholera toxin by human ARF6-GTP". Science 309 (5737): 1093–6. doi:10.1126/science.1113398. PMID 16099990.
- ^ a b c DiRita VJ, Parsot C, Jander G, Mekalanos JJ (June 1991). "Regulatory cascade controls virulence in Vibrio cholerae". Proc. Natl. Acad. Sci. U.S.A. 88 (12): 5403–7. doi:10.1073/pnas.88.12.5403. PMC 51881. PMID 2052618. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=51881.
- ^ Lan R, Reeves PR (Jan 2002). "Pandemic Spread of Cholera: Genetic Diversity and Relationships within the Seventh Pandemic Clone of Vibrio cholerae Determined by Amplified Fragment Length Polymorphism". Journal of Clinical Microbiology 40 (1): 172–181. doi:10.1128/JCM.40.1.172-181.2002. ISSN 0095-1137. PMC 120103. PMID 11773113. http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=11773113.
- ^ "Laboratory Methods for the Diagnosis of Epidemic Dysentery and Cholera" (PDF). Atlanta, GA: CDC. 1999. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/cholera/top.pdf. Retrieved 2010-02-01.
- ^ "Cholera Kills Boy. All Other Suspected Cases Now in Quarantine and Show No Alarming Symptoms." (PDF). New York Times. July 18, 1911. http://query.nytimes.com/mem/archive-free/pdf?res=990CEFD61431E233A2575BC1A9619C946096D6CF. Retrieved 2008-07-28. "The sixth death from cholera since the arrival in this port from Naples of the steamship Moltke, thirteen days ago, occurred yesterday at Swineburne Island. The victim was Francesco Farando, 14 years old."
- ^ "More Cholera in Port". Washington Post. October 10, 1910. http://pqasb.pqarchiver.com/washingtonpost_historical/access/250061412.html?dids=250061412:250061412&FMT=ABS&FMTS=ABS:FT&date=OCT+10%2C+1910&author=&pub=The+Washington+Post&desc=MORE+CHOLERA+IN+PORT&pqatl=google. Retrieved 2008-12-11. "A case of cholera developed today in the steerage of the Hamburg-American liner Moltke, which has been detained at quarantine as a possible cholera carrier since Monday last. Dr. A.H. Doty, health officer of the port, reported the case tonight with the additional information that another cholera patient from the Moltke is under treatment at Swinburne Island."
- ^ "Cholera: prevention and control". Health topics. WHO. 2008. http://www.who.int/topics/cholera/control/en/index.html. Retrieved 2008-12-08.
- ^ a b Sinclair D, Abba K, Zaman K, Qadri F, Graves PM (2011). "Oral vaccines for preventing cholera". Cochrane Database Syst Rev (3): CD008603. doi:10.1002/14651858.CD008603.pub2. PMID 21412922.
- ^ "Is a vaccine available to prevent cholera?". CDC disease info: Cholera. 2010-10-22. http://www.cdc.gov/cholera/general/#vaccine. Retrieved 2010-10-24.
- ^ Graves PM, Deeks JJ, Demicheli V, Jefferson T (2010). Graves, Patricia M. ed. "Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)". Cochrane Database Syst Rev (8): CD000974. doi:10.1002/14651858.CD000974.pub2. PMID 20687062.
- ^ "Cholera vaccines". Health topics. WHO. 2008. http://www.who.int/topics/cholera/vaccines/en/index.html. Retrieved 2010-02-01.
- ^ a b THE TREATMENT OF DIARRHOEA, A manual for physicians and other senior health workers, World Health Organization, 2005. See page 10 (14 in PDF) and esp chapter “5. MANAGEMENT OF SUSPECTED CHOLERA,” pages 16-17 (20-21 in PDF).
- ^ Community Health Worker Training Materials for Cholera Prevention and Control, CDC, slides at back are dated 11/17/2010. See esp pages 7-8.
- ^ The Civil War That Killed Cholera, foreignpolicy.com.
- ^ "Oral Rehydration Solutions: Made at Home". The Mother and Child Health and Education Trust. 2010. http://rehydrate.org/solutions/homemade.htm. Retrieved 2010-10-29.
- ^ "Cholera treatment". Molson Medical Informatics. 2007. http://sprojects.mmi.mcgill.ca/tropmed/disease/chol/treatment.htm. Retrieved 2008-01-03.
- ^ Krishna BV, Patil AB, Chandrasekhar MR (March 2006). "Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India". Trans. R. Soc. Trop. Med. Hyg. 100 (3): 224–6. doi:10.1016/j.trstmh.2005.07.007. PMID 16246383. http://linkinghub.elsevier.com/retrieve/pii/S0035-9203(05)00237-3.
- ^ Mackay IM (editor) (2007). Real-Time PCR in microbiology: From diagnosis to characterization. Caister Academic Press. ISBN 978-1-904455-18-9.
- ^ Ramamurthy T (2008). "Antibiotic resistance in Vibrio cholerae". Vibrio cholerae: Genomics and molecular biology. Caister Academic Press. ISBN 978-1-904455-33-2.
- ^ Ali M, Emch M, Yunus M, Sack D, Lopez AL, Holmgren J, Clemens J (Jan 2008). "Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission". Pediatr Infect Dis J 27 (1): 33–7. doi:10.1097/INF.0b013e318149dffd. PMID 18162935.
- ^ Z. Bhutta. Background Paper on the Integration of Oral Cholera Vaccines into Global Cholera Control Programmes. To be presented to the WHO SAGE in October 2009
- ^ Stanton BF, Clemens JD, Clements JD (1986). "Soiled saris: a vector of disease transmission?". Trans R Soc Trop Med Hyg 80 (3): 485–8. PMID 3798547.
- ^ Todar, Kenneth. "Vibrio cholerae and Asiatic Cholera". Todar's Online Textbook of Bacteriology. http://www.textbookofbacteriology.net/cholera.html. Retrieved 2010-12-20.
- ^ NPR News. Presenter: Richard Knox. NPR. 2010-12-10.
- ^ Reidl J, Klose KE (June 2002). "Vibrio cholerae and cholera: out of the water and into the host". FEMS Microbiol. Rev. 26 (2): 125–39. doi:10.1111/j.1574-6976.2002.tb00605.x. PMID 12069878.
- ^ Blake, PA (1993). "Epidemiology of cholera in the Americas". Gastroenterology clinics of North America 22 (3): 639–60. PMID 7691740.
- ^ "Cholera's seven pandemics". CBC News. October 22, 2010.
- ^ .Kelley Lee (2003) "Health impacts of globalization: towards global governance". Palgrave Macmillan. p.131. ISBN 0333802543
- ^ Geoffrey A. Hosking (2001). "Russia and the Russians: a history". Harvard University Press. p.9. ISBN 0674004736
- ^ Byrne, Joseph Patrick (2008). Encyclopedia of Pestilence, Pandemics, and Plagues: A-M. ABC-CLIO. p. 99. ISBN 0313341028. http://books.google.com/books?id=5Pvi-ksuKFIC&pg=PA99&dq#v=onepage&q=&f=false.
- ^ J. N. Hays (2005). "Epidemics and pandemics: their impacts on human history". p.347. ISBN 1851096582
- ^ Sehdev PS (November 2002). "The origin of quarantine". Clin. Infect. Dis. 35 (9): 1071–2. doi:10.1086/344062. PMID 12398064.
- ^ "Archaic medical terms". Antiquus Morbus. 2007. http://www.antiquusmorbus.com/English/EnglishC.htm. Retrieved 2010-02-01.
- ^ Rosenberg, Charles E. (1987). The cholera years: the United States in 1832, 1849 and 1866. Chicago: University of Chicago Press. ISBN 0-226-72677-0.
- ^ Dr John Snow, The mode of communication of cholera, London 1855
- ^ Merrell DS, Butler SM, Qadri F, et al. (June 2002). "Host-induced epidemic spread of the cholera bacterium". Nature 417 (6889): 642–5. doi:10.1038/nature00778. PMC 2776822. PMID 12050664. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2776822.
- ^ Brown, Man and Music, 430–32; Holden, 371; Warrack, Tchaikovsky, 269–270.
- ^ Meumayr A (1997). Music and medicine: Chopin, Smetana, Tchaikovsky, Mahler: Notes on their lives, works, and medical histories. Med-Ed Press. pp. 282–3. (summarizing various theories on what killed the composer Tchaikovsky, including his brother Modest's idea that Tchaikovsky drank cholera-infested water the day before he became ill).
- ^ David Brown, Early Years, 46.
- ^ Holden, 23.
- ^ Brown, Man and Music, 431–35; Holden, 373–400.
- ^ Susan Nagel, Marie Thérèse: Child of Terror, p. 349-350.
- ^ Haynes, Sam W. (1997). James K. Polk and the Expansionist Impulse. New York: Longman. p. 191. ISBN 978-0-673-99001-3.
- ^ Smith, Rupert, The Utility of Force, Penguin Books, 2006, page 57
- ^ Burnshaw S (2000). "Robert Frost". American National Biography Online. Archived from the original on 2001-03-18. http://www.english.uiuc.edu/maps/poets/a_f/frost/life.htm.
- Colwell RR (December 1996). "Global climate and infectious disease: the cholera paradigm". Science 274 (5295): 2025–31. doi:10.1126/science.274.5295.2025. PMID 8953025. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=8953025.
- Drasar, B. S.; Forrest, Bruce D., eds (1996). Cholera and the ecology of Vibrio cholerae. Springer. p. 355. ISBN 0412612208. http://books.google.com/?id=NNQtXqqnVSIC&printsec=frontcover
- Myron Echenberg: Africa in the Time of Cholera. A History of Pandemics from 1817 to the Present, Cambridge University Press, New York 2011 (Paperback) ISBN 978-0-521-18820-3
- Furuque, Shah M.; Nair, G. Balakrish, eds (2008). Vibrio Cholerae: Genomics and Molecular Biology. Horizon Scientific Press. p. 218. ISBN 1904455336. http://books.google.com/?id=fP67F_eOSgQC&printsec=frontcover
- Gilbert, Pamela K. (2008). Cholera and Nation: Doctoring the Social Body in Victorian England. SUNY Press. p. 231. ISBN 0791473430. http://books.google.com/?id=nzr71cHdiNkC&printsec=frontcover
- Jermyn, William S.; O'Shea, Yvonne A.; Quirke, Anne Marie; Boyd, E. Fidelma (2006). "Genomics and the Evolution of Pathogenic Vibrio Cholerae". In Chan, Voon L.; Sherman, Philip M.; Bourke, Billy. Bacterial genomes and infectious diseases. Humana Press. p. 270. ISBN 158829496X. http://books.google.com/?id=SX862lszVM4C&printsec=frontcover
- Johnson, Steven (2006). The Ghost Map: The Story of London's Most Terrifying Epidemic--and How It Changed Science, Cities, and the Modern World (1854 epidemic). Riverhead Hardcover. ISBN 1594489254.
- Mintz ED, Guerrant RL (March 2009). "A lion in our village--the unconscionable tragedy of cholera in Africa". N. Engl. J. Med. 360 (11): 1060–3. doi:10.1056/NEJMp0810559. PMID 19279337. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=19279337&promo=ONFLNS19.
- Pardio Sedas, Violeta T. (2008). "Impact of Climate and Environmental Factors on the Epidemiology of Vibrio choerae in Aquatic Ecosystems". In Hofer, Tobias N.. Marine Pollution: New Research. Nova Science publishers. p. 448. pp. 221–254. ISBN 1604562420. http://books.google.com/?id=LYYXNnA1swcC&printsec=frontcover
- Ryan, Kenneth J.; Ray, C. George, eds (2003). Sherris medical microbiology: an introduction to infectious diseases (4th ed.). ISBN 0838585299. http://books.google.com/?id=mcjQ96KsQ_EC&printsec=frontcover
- Wachsmuth, Kaye; Blake, Paul A.; Olsvik, Ørjan, eds (1994). Vibrio cholerae and cholera: molecular to global perspectives. ASM Press. p. 465. ISBN 1555810675. http://books.google.com/?id=xBhwzHQkdkYC&printsec=frontcover
- Cholera - World Health Organization
- The Attenuation of the Causal Agent of Fowl Cholera, by Louis Pasteur, 1880
- What is Cholera? - Centers for Disease Control and Prevention
- Steven Shapin, "Sick City: Maps and mortality in the time of cholera", The New Yorker May 2006. A review of Steven Johnson, “The Ghost Map: The story of London’s most terrifying epidemic — and how it changed science, cities, and the modern world”
- Cholera Epidemic in NYC in 1832 New York Times 15 April 2008
- The Cholera Timebomb in The DRC - slideshow by The First Post
Cholera Cholera Cholera Bacteria Treatment OutbreaksOther outbreaks: 1854 Broad Street cholera outbreak - 2007 Central Luzon hog cholera outbreak - 2007 Iraq cholera outbreak - 2008 Congo cholera outbreak - 2008–2009 Zimbabwean cholera outbreak - 2010 Haiti cholera outbreak Diseases of poverty Diseases of poverty Neglected diseases Miscellaneous Infectious diseases · Bacterial diseases: Proteobacterial G− (primarily A00–A79, 001–041, 080–109) αRickettsia rickettsii (Rocky Mountain spotted fever) · Rickettsia conorii (Boutonneuse fever) · Rickettsia japonica (Japanese spotted fever) · Rickettsia sibirica (North Asian tick typhus) · Rickettsia australis (Queensland tick typhus) · Rickettsia honei (Flinders Island spotted fever) · Rickettsia africae (African tick bite fever) · Rickettsia parkeri (American tick bite fever) · Rickettsia aeschlimannii (Rickettsia aeschlimannii infection)Rickettsia felis (Flea-borne spotted fever)Brucella abortus (Brucellosis) β γH2S-VibrionalesXanthomonadalesCardiobacterialesCardiobacterium hominis (HACEK) ε
Wikimedia Foundation. 2010.